You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

HOME Hepatitis C Hepatitis B HIV and AIDS HIV-HCV Coinfection HIV-HBV Coinfection About Us

HIV and Hepatitis.com Coverage of  Digestive Disease Week (DDW 2009) -May 30 - June 4, 2009, Chicago, Illinois

Library of Slides and Posters Hepatitis B Articles Hepatitis C Articles HIV-HCV or HIV-HBV Coinfection Articles Sign up to receive our twice-weekly e-Newsletter       Library of Slides and Posters Hepatitis B Slides and Posters Entecavir (ETV) Therapy in Chronic Hepatitis B Patients Previously Treated with Adefovir (ADV) with Incomplete Response On-Treatment or Relapse Off-Treatment N Leung and others. DDW 2009. Long-Term Histological Improvement with Entecavir (ETV) Therapy in Patients with Chronic Hepatitis B (CHB) from Japanese and Worldwide Development Programs Y Liaw and others. DDW 2009. Entecavir Maintains a High Genetic Barrier to HBV Resistance Through 6 Years in Naïve Patients D Tenney and others. DDW 2009. Regression of Fibrosis/Cirrhosis with Long-Term Entecavir Therapy in Chronic Hepatitis B (CHB) Patients with Baseline Bridging Fibrosis or Cirrhosis: Results from Studies ETV-022, -027 and -901 E Schiff and others. DDW 2009. Association between HBV Replication and Serum ALT Changes is not Dependent on HBV Genotype and Mutants H Yang and others. DDW 2009. Risk and Predictors of HCC in People Less than 40 years of Age: Update from the R.E.V.E.A.L.-HBV Study C Chen and others. DDW 2009.   Hepatitis C Slides and Posters HIV-HCV Coinfected and HCV Monoinfected Patients with Genotype 2-3 Respond Equally Well to 24 Weeks of Pegylated Interferon plus Ribavirin Top       Hepatitis C Articles Many People with Chronic Hepatitis B and C Do Not Receive Appropriate Treatment 6-16-2009 Older Genotype 3 Chronic Hepatitis C Patients Do Not Respond as Well to Interferon-based Therapy 6-16-2009 Asian-American Chronic Hepatitis C Patients Respond Well to Pegylated Interferon plus Ribavirin 6-12-2009 Asian-Americans Are More Likely to Have Unknown Hepatitis C Virus Transmission Risk Factors 6-12-2009 Metabolic Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients 6-9-2009 Strategies for Managing Acetaminophen-related Liver Disease and Acute Liver Failure 6-5-2009 Vitamin B12 Levels May Help Predict Response to Interferon-based Therapy for Chronic Hepatitis C 6-5-2009 Top       Hepatitis B Articles Predictors of Sustained Treatment Response in HIV-HCV Coinfected Patients Receiving Routine Care 6-16-2009 Many People with Chronic Hepatitis B and C Do Not Receive Appropriate Treatment 6-16-2009 Hepatitis B Prevalence and Susceptibility among Immigrant and U.S.-born Asians and Pacific Islanders 6-12-2009 High HBV DNA Level Is the Strongest Predictor of Elevated ALT 6-9-2009 Should Entecavir (Baraclude) and Tenofovir (Viread) Be First-line Treatment for Chronic Hepatitis B? 6-5-2009 Slides and Posters on Entecavir (Baraclude) and Hepatitis B Liver Disease Progression Presented at DDW 2009 6-5-2009 Top       HIV-HCV or HIV-HBV Coinfection Articles Does HIV-HCV Coinfection Increase the Risk of Liver Disease Progression and Worsen Clinical Outcomes? 6-9-2009 HIV-HCV Coinfected and HCV Monoinfected Patients with Genotype 2-3 Respond Equally Well to 24 Weeks of Pegylated Interferon plus Ribavirin                                                         FDA-approved Combination Therapies for Chronic HCV Infection Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin FDA-approved Therapies for Chronic HBV Infection Baraclude  (entecavir) Epivir-HBV  (lamivudine; 3TC) Hepsera   (adefovir dipivoxil) Intron A  (interferon alfa-2b) Pegasys  (peginterferon alfa-2a) Viread  (tenofovir) Tyzeka   (telbivudine)

HIV and Hepatitis.com is published by HIV and Hepatitis Treatment Advocates, Inc.